USAHS Pharmacology Final Exam Questions
and Answers with Verified Solutions | Latest
Updated 2026
A 45-year-old patient presents with B) Prostaglandins cause uterine smooth
severe dysmenorrhea and reports muscle
that NSAIDs provide significant contraction and inflammation.
relief. Which of the following best
explains the role of prostaglandins
in
this condition?
A) Prostaglandins increase platelet
aggregation, leading to pain.
B) Prostaglandins cause uterine
smooth muscle contraction and
inflammation.
C) Prostaglandins inhibit the
release
of inflammatory mediators.
D) Prostaglandins reduce vascular
permeability, decreasing blood
flow.
,A patient with a history of peptic C) Reduced gastric mucosal protection
ulcer disease presents with
abdominal pain and is found to
have
excessive gastric acid secretion.
Which of the following is most
likely
linked to prostaglandin deficiency
rather than excessive synthesis?
A) Increased mucus production in
the stomach
B) Decreased gastric acid
secretion
C) Reduced gastric mucosal
protection
D) Enhanced bicarbonate
secretion
Which of the following conditions B) Rheumatoid arthritis
is
most directly associated with
excessive prostaglandin
synthesis?
A) Hypertension
B) Rheumatoid arthritis
C) Osteoporosis
D) Hyperthyroidism
,A patient taking a nonselective A) Inhibition of COX-1 reduces protective
NSAID develops gastrointestinal prostaglandins in the gastric mucosa.
discomfort. Which of the following
best explains this adverse effect?
A) Inhibition of COX-1 reduces
protective prostaglandins in the
gastric mucosa.
B) Inhibition of COX-2 increases
gastric acid secretion.
C) Nonselective NSAIDs increase
prostaglandin synthesis in the
stomach.
D) COX-2 inhibition reduces
platelet
aggregation, leading to gastric
bleeding.
Which of the following is a key B) Reduced risk of gastrointestinal side
advantage of COX-2 inhibitors effects
over
nonselective NSAIDs?
A) Reduced risk of cardiovascular
events
B) Reduced risk of gastrointestinal
side effects
C) Increased anti-inflammatory
potency
D) Increased inhibition of platelet
aggregation
, A patient with a history of C) Aspirin (low-dose)
myocardial
infarction is prescribed an NSAID.
Which of the following is the most
appropriate choice to minimize
cardiovascular risk?
A) Celecoxib (COX-2 inhibitor)
B) Ibuprofen (nonselective NSAID)
C) Aspirin (low-dose)
D) Naproxen (nonselective
NSAID)
A 60-year-old patient with a history B) Inhibit platelet aggregation to prevent
of coronary artery disease is thrombosis
prescribed low-dose aspirin. What
is
the primary therapeutic goal of this
treatment?
A) Reduce inflammation in the
coronary arteries
B) Inhibit platelet aggregation to
prevent thrombosis
C) Decrease blood pressure by
reducing vascular resistance
D) Relieve chest pain by reducing
myocardial oxygen demand
and Answers with Verified Solutions | Latest
Updated 2026
A 45-year-old patient presents with B) Prostaglandins cause uterine smooth
severe dysmenorrhea and reports muscle
that NSAIDs provide significant contraction and inflammation.
relief. Which of the following best
explains the role of prostaglandins
in
this condition?
A) Prostaglandins increase platelet
aggregation, leading to pain.
B) Prostaglandins cause uterine
smooth muscle contraction and
inflammation.
C) Prostaglandins inhibit the
release
of inflammatory mediators.
D) Prostaglandins reduce vascular
permeability, decreasing blood
flow.
,A patient with a history of peptic C) Reduced gastric mucosal protection
ulcer disease presents with
abdominal pain and is found to
have
excessive gastric acid secretion.
Which of the following is most
likely
linked to prostaglandin deficiency
rather than excessive synthesis?
A) Increased mucus production in
the stomach
B) Decreased gastric acid
secretion
C) Reduced gastric mucosal
protection
D) Enhanced bicarbonate
secretion
Which of the following conditions B) Rheumatoid arthritis
is
most directly associated with
excessive prostaglandin
synthesis?
A) Hypertension
B) Rheumatoid arthritis
C) Osteoporosis
D) Hyperthyroidism
,A patient taking a nonselective A) Inhibition of COX-1 reduces protective
NSAID develops gastrointestinal prostaglandins in the gastric mucosa.
discomfort. Which of the following
best explains this adverse effect?
A) Inhibition of COX-1 reduces
protective prostaglandins in the
gastric mucosa.
B) Inhibition of COX-2 increases
gastric acid secretion.
C) Nonselective NSAIDs increase
prostaglandin synthesis in the
stomach.
D) COX-2 inhibition reduces
platelet
aggregation, leading to gastric
bleeding.
Which of the following is a key B) Reduced risk of gastrointestinal side
advantage of COX-2 inhibitors effects
over
nonselective NSAIDs?
A) Reduced risk of cardiovascular
events
B) Reduced risk of gastrointestinal
side effects
C) Increased anti-inflammatory
potency
D) Increased inhibition of platelet
aggregation
, A patient with a history of C) Aspirin (low-dose)
myocardial
infarction is prescribed an NSAID.
Which of the following is the most
appropriate choice to minimize
cardiovascular risk?
A) Celecoxib (COX-2 inhibitor)
B) Ibuprofen (nonselective NSAID)
C) Aspirin (low-dose)
D) Naproxen (nonselective
NSAID)
A 60-year-old patient with a history B) Inhibit platelet aggregation to prevent
of coronary artery disease is thrombosis
prescribed low-dose aspirin. What
is
the primary therapeutic goal of this
treatment?
A) Reduce inflammation in the
coronary arteries
B) Inhibit platelet aggregation to
prevent thrombosis
C) Decrease blood pressure by
reducing vascular resistance
D) Relieve chest pain by reducing
myocardial oxygen demand
